LIVE WEBINAR
Revolutionizing Neuroscience with HUGO-GT™ Humanized Mouse Models
Join us to discover how Cyagen’s HUGO-GT™ humanized mouse models—featuring full-length human gene replacements—are reshaping the way we study neurodegenerative and neurodevelopmental diseases. This webinar includes a case study on Rett syndrome and introduces comprehensive CRO services tailored for neuroscience drug discovery.
DATE
12:00 PM – 1:00 PM EST
LOCATION
Online Webinar | YouTube
Webinar Overview
Join us for an exclusive webinar exploring how Cyagen’s next-generation HUGO-GT™ humanized mouse models are transforming neuroscience research. These models offer in situ replacement of mouse genes with full-length human orthologs—capturing regulatory elements, exons, introns, and UTRs—providing greater translational relevance for neurodegenerative and neurodevelopmental disease studies.
The webinar will also showcase a real-world case study featuring the hMECP2 model for Rett syndrome research and present Cyagen’s broader lineup of neuroscience-related models. In addition, attendees will be introduced to Cyagen’s dedicated CRO platform, which integrates behavioral assays and in vivo validation services to support preclinical neuroscience programs.
Topic Covered
- HUGO-GT™ technology and full-length human gene replacement
- Case study: hMECP2 model for neurodevelopmental research
- Overview of disease models for Alzheimer’s, epilepsy, etc.
- Introduction to Cyagen’s neuroscience-focused CRO platform
Who Should Attend
- Researchers in neuroscience, genetics, and translational medicine
- Professionals developing gene therapies (ASO, siRNA, AAV, LNP, etc.)
- Scientists seeking advanced preclinical models for CNS studies
Attend this Webinar to:
- Discover humanized models that improve disease relevance
- Learn from real data in a neurodevelopmental model case
- Explore full-service CRO support for neurological research
Webinar Presenter
{{value.name}}
{{value.title}}
{{value.company}}
{{value.descript}}
Discover Our Solutions
Cyagen’s HUGO-GT™ platform provides advanced humanized mouse models that enable more accurate and translational research in neurological diseases. Paired with our neuroscience-focused CRO services—including behavioral phenotyping, efficacy evaluation, and in vivo analysis—we offer comprehensive support for preclinical studies from model generation to therapeutic validation.
{{ value.label }}
{{ value.name }}
Explore
Request Information About This Webinar
Whether you're joining live or catching up later, fill out the form to receive materials or updates related to this webinar.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.